Reported Sep 11, 2024 · Ongoing

TIRZEPATIDE 60 mg/3mL (20/mg/mL), Rx Only, 3mL Multiple Dose Vial, Mfd by: ProRx Exton, PA, 19341, NDC 84139-210-02

ProRx LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: ProRx LLC · 619 Jeffers Cir · Exton, PA · 19341-2540

Is this the product you have?

    • TIRZEPATIDE 60 mg/3mL (20/mg/mL)
    • Rx Only
    • 3mL Multiple Dose Vial
  • Mfd byProRx Exton, PA, 19341, NDC 84139-210-02
Lot codes and dates
    • Lot# ProRx052224
    • BUD 11/21/2024 ProRx061024
    • BUD 12/09/2024
Amount recalled
1,732 vials

This recall covers 7 products

The agency filed one notice per product. You are reading one of them; the other 6 are below.

Where it was sold

  • Nationwide

Why it was recalled

Lack of Assurance of Sterility

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new ProRx LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA drug enforcement) notice

Data as of Sep 19, 8:03 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.